Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?

J Hepatol. 2006 Feb;44(2):253-61. doi: 10.1016/j.jhep.2005.11.030. Epub 2005 Dec 1.

Authors

Claire Z Larter¹, Geoffrey C Farrell

Affiliation

¹ The Storr Liver Unit, Westmead's Millennium Institute, University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.

PMID: 16364488
DOI: 10.1016/j.jhep.2005.11.030

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Adiponectin / blood*
Cytokines / blood*
Fatty Liver / blood*
Fatty Liver / therapy
Humans
Insulin Resistance / physiology*
Life Style
Prognosis
Weight Loss

Substances

Adiponectin
Cytokines